Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct viral clades of SARS‐CoV‐2: Implications for modeling of viral spread
Adam Brufsky
Journal of Medical Virology (2020) Vol. 92, Iss. 9, pp. 1386-1390
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Geographic and Genomic Distribution of SARS-CoV-2 Mutations
Daniele Mercatelli, Federico M. Giorgi
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 640
Infection fatality rate of COVID-19 inferred from seroprevalence data
John P. A. Ioannidis
Bulletin of the World Health Organization (2020) Vol. 99, Iss. 1, pp. 19-33F
Open Access | Times Cited: 565
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
Bette Korber, WM Fischer, S. Gnanakaran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 524
Emergence of SARS-CoV-2 through recombination and strong purifying selection
Xiaojun Li, Elena E. Giorgi, Manukumar Honnayakanahalli Marichannegowda, et al.
Science Advances (2020) Vol. 6, Iss. 27
Open Access | Times Cited: 406
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
Xianding Deng, Wei Gu, Scot Federman, et al.
Science (2020) Vol. 369, Iss. 6503, pp. 582-587
Open Access | Times Cited: 289
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar, Katherine K. Perez, Madiha Ashraf, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 8, pp. 1680-1690
Open Access | Times Cited: 285
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P. A. Ioannidis
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 215
Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
Ma’mon M. Hatmal, Walhan Alshaer, Mohammad A. I. Al-Hatamleh, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2638-2638
Open Access | Times Cited: 180
Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants
Rui Wang, Jiahui Chen, Kaifu Gao, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 172
Phylogenetic Analysis of SARS-CoV-2 Data Is Difficult
Benoît Morel, Pierre Barbera, Lucas Czech, et al.
Molecular Biology and Evolution (2020) Vol. 38, Iss. 5, pp. 1777-1791
Open Access | Times Cited: 155
Post-COVID-19 travel behaviour patterns: impact on the willingness to pay of users of public transport and shared mobility services in Spain
Samir Awad-Núñez, Raky Julio, Juan Gómez, et al.
European Transport Research Review (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 149
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States
Michael Fried, Julie M. Crawford, Andrea R. Mospan, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 10, pp. e558-e565
Open Access | Times Cited: 147
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
Poduri Ramarao, Gaurav Joshi, Gowraganahalli Jagadeesh
Cellular Signalling (2020) Vol. 74, pp. 109721-109721
Open Access | Times Cited: 145
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology
Samira M. Hamed, Walid F. Elkhatib, Ahmed S. Khairalla, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 94
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19
Sachin J. Shah, Peter Barish, Priya A. Prasad, et al.
EClinicalMedicine (2020) Vol. 27, pp. 100518-100518
Open Access | Times Cited: 82
Age and COVID-19 mortality: A comparison of Gompertz doubling time across countries and causes of death
Isaac Sasson
Demographic Research (2021) Vol. 44, pp. 379-396
Open Access | Times Cited: 76
Questions concerning the proximal origin of SARS‐CoV‐2
Murat Seyran, Damiano Pizzol, Parise Adadi, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 3, pp. 1204-1206
Open Access | Times Cited: 72
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
Maxwell T. Finkelstein, Adam G. Mermelstein, Emma Parker Miller, et al.
Viruses (2021) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 71
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
Pedro F.N. Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, et al.
International Journal of Biological Macromolecules (2022) Vol. 208, pp. 105-125
Open Access | Times Cited: 60
Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds
Hassaan Malik, Tayyaba Anees
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0296352-e0296352
Open Access | Times Cited: 8
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
Pasquale Campana, Valentina Parisi, Dario Leosco, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 2046-2046
Open Access | Times Cited: 58
The Enigma of Low COVID-19 Fatality Rate in India
Arghadip Samaddar, Ravisekhar Gadepalli, Vijaya Lakshmi Nag, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 52
DC/L‐SIGNs of hope in the COVID‐19 pandemic
Adam Brufsky, Michael T. Lotze
Journal of Medical Virology (2020) Vol. 92, Iss. 9, pp. 1396-1398
Open Access | Times Cited: 50
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12638-12638
Open Access | Times Cited: 50
Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
Christian Devaux, Lucile Pinault, Ikram Omar Osman, et al.
Frontiers in Public Health (2021) Vol. 8
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top